NPI registry status
Active
2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician NPI 1881853877 M.D.
Verify on CMS → Benjamin Dillon, M.D.
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 121 in Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 775 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician avg: 1K
Industry payments
$36.66
1 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Benjamin Dillon, M.D. filed 2,627 Medicare Part D claims in 2024 as a Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician in Houston, Texas.
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Benjamin Dillon, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1881853877), first enumerated 06/04/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,627 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$36.66 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Benjamin Dillon, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Dillon with other Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Texas
- Dr. Jessie Chen, M.D. Flower Mound, TX
- Khadijah Eid, MBBS , MSCS, SB-URO Houston, TX
- Dr. Richard Farnam, MD El Paso, TX
- Dr. Kathleen Kobashi, MD Houston, TX
- Dr. James Oyekan, MD Jbsa Fort Sam Houston, TX
- Dr. Melissa Sanford, M.D. Lubbock, TX
Other specialties in Houston: Student in an Organized Health Care Education/Training Program (4,947) · Pharmacist (2,349) · Behavior Technician (2,305) · Family Nurse Practitioner (2,271)
CMS NPPES provider registry desk
NPI 1881853877 · Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
NPI-10 · ENUM-MID · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1881853877
- ENUM-MID 2008
- TAX-TRACE 121
- RX-MID 2,627
- BOOK-THIN 10 in Texas
- PHOTO-ENUM Bilal Chughtai, MD · 2008
Benjamin Dillon, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,627 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Benjamin Dillon, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Benjamin Dillon, M.D.?
Quality data not reportedPrimary specialty
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
Medicare Part D claims
2,627 122% vs specialty avg
Specialty distribution in Texas
How Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1881853877 |
|---|---|
| Specialty | Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/04/2008 |
Hospital and facility affiliations
Facilities where Benjamin Dillon, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kelsey-Seybold Medical Group, PLLC
Houston, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Benjamin Dillon, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$37
Largest payer
Laborie Medical Technologies Corp.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Benjamin Dillon, M.D.. To verify Benjamin Dillon, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,627
Total Claims
$325K
Total Drug Cost
775
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,062.5
- Total Day Supply
- 138,321
- Generic Drug Cost
- $150K
- Opioid Claims
- 43 (1.6% rate)
- Antibiotic Claims
- 563
Patient Demographics
- Average Patient Age
- 76.1 years
- Avg HCC Risk Score
- 1.68
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 22, 65-74: 299, 75-84: 348, 85+: 106
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Benjamin Dillon, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Oxybutynin Chlorid…
Oxybutynin Chloride Er
590 claims
- Tamsulosin Hcl
Tamsulosin Hcl
325 claims
- Myrbetriq 188
Myrbetriq
188 claims
- Estradiol 167
Estradiol
167 claims
- Trospium Chloride Er 163
Trospium Chloride Er
163 claims
- Nitrofurantoin Mon… 146
Nitrofurantoin Mono-Macro
146 claims
- Darifenacin Er 134
Darifenacin Er
134 claims
- Cefpodoxime Proxetil 111
Cefpodoxime Proxetil
111 claims
| Drug | Claims |
|---|---|
| Oxybutynin Chloride Er Oxybutynin Chloride | 590 |
| Tamsulosin Hcl | 325 |
| Myrbetriq Mirabegron | 188 |
| Estradiol | 167 |
| Trospium Chloride Er Trospium Chloride | 163 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 146 |
| Darifenacin Er Darifenacin Hydrobromide | 134 |
| Cefpodoxime Proxetil | 111 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 89 |
| Finasteride | 87 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician in TX →
All providers in Texas →
Compare specialties →
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Overview
How Benjamin Dillon, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician landscape nationally.
121
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in US
29
States with Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
1,181
Avg Claims per Provider
Benjamin Dillon, M.D.'s 2,627 claims are above the specialty average of 1,181.
Nationwide Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Dillon, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Dillon.
One of 10 Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers enrolled in Texas, 9 are shown on this page.
Frequently Asked Questions
What is Benjamin Dillon, M.D.'s specialty? ▼
Benjamin Dillon, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician and practices in Houston, Texas. Credentials: M.D..
How much does Benjamin Dillon, M.D. prescribe under Medicare Part D? ▼
In 2024, Benjamin Dillon, M.D. wrote 2,627 Medicare Part D claims totaling $325K in drug costs for 775 beneficiaries.
Where is Benjamin Dillon, M.D. located? ▼
Benjamin Dillon, M.D. is located at 2727 W HOLCOMBE BLVD, Houston, TX, 77025. Phone: (713) 442-1019.
What is Benjamin Dillon, M.D.'s NPI number? ▼
Benjamin Dillon, M.D.'s National Provider Identifier (NPI) is 1881853877, issued on 06/04/2008.
Does Benjamin Dillon, M.D. prescribe opioids? ▼
Yes, Benjamin Dillon, M.D. had 43 opioid claims in 2024 with an opioid prescribing rate of 1.6%.
How many Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers are there in the US? ▼
There are 121 Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers across 29 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider writes 1,181 Medicare Part D claims per year.
What drugs does Benjamin Dillon, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Benjamin Dillon, M.D.'s most frequently prescribed drugs include Oxybutynin Chloride Er, Tamsulosin Hcl, Myrbetriq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Benjamin Dillon, M.D. accept Medicare? ▼
Benjamin Dillon, M.D. appears in CMS Medicare data with 2,627 Part D claims and 775 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Benjamin Dillon, M.D.'s credentials? ▼
Benjamin Dillon, M.D.'s NPI is 1881853877 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.